Prostate Cancer Prostate cancer is the most common cancer detected in American men. The lifetime risk of a 50-year-old man for latent CaP is 40%; for.

Slides:



Advertisements
Similar presentations
Investigation and Management of Prostate Cancer
Advertisements

Prostate cancer diagnosis today Mungai Ngugi. Introduction Prostate cancer remains a major problem in the world and particularly in black people who have.
PROSTATE CANCER Dr Samad Zare Assistant Proffesor of Urology Shaheed Sadoughi University of Medical Sciences.
Advanced Stage Prostate Cancer Management Michael E. Karellas Assistant Professor of Urologic Oncology May 15, 2010.
"My urine flow is poor”. Shane is 65-years old and complains of a 4 to 5-month history of progressive difficulty voiding. He finds it difficult to start.
THE CLINICO-PATHOLOGIC PATTERNS OF PROSTATIC DISEASES AND PROSTATE CANCER IN SAUDI PATIENTS Hisham A. M. Mosli, FRCSC, FACS Taha A. Abdel-Meguid, MD Jaudah.
Epidemiology of prostate cancer Epidemiology and Molecular Pathology of Cancer: Bootcamp course Tuesday, 3 January 2012.
Carcinoma of the Prostate By: Ishan Parikh. Background on Cancer  Oldest information dates back to 3000 BC, Egyptian textbook on trauma surgery – “There.
CA of Prostate:Incidence In a 50 y/o man In a 50 y/o man In autopsy: 40% In autopsy: 40% Clinical: 10% Clinical: 10% Death: 3% Death: 3% Most common non-cutanous.
Prostate cancer: early detection, monitoring and prognosis: Essex Biomedical Sciences Institute (EBSI) Elena Klenova, University of Essex the search for.
Prostate Pathophysiology Charles L. Hitchcock, MD PhD Associate Professor - Clinical Department of Pathology.
AM Report 9/11/09 Prostate Cancer Julia Rauch. Disease Burden ~220,000 men were diagnosed with prostate cancer in 2007 ~1/6 men will receive the disagnosis.
Prostate Cancer Cancer: Cancer is a term used for diseases in which abnormal cells divide without control and are able to invade other tissues. Cancer.
NEW OPTIONS IN PROSTATE CANCER TREATMENT Presented by Triangle Urology Associates, P.A.
Prostate Cancer Education Seminar. What is the Prostate? A male sex gland The size of a walnut below the bladder and in front of the rectum Produces the.
Prostate Cancer. Statistics of prostate cancer Incidence Prostate- 32% Lung – 16% Mortality Lung- 33% Prostate 13%
Colorectal cancer Khayal AlKhayal MD,FRCSC
Prostate Cancer Int. 洪 毓 謙. Prostate cancer is the Second leading cause of death from cancer in the United States American male, the lifetime risk of:
Objectives: Our first segment focused in the anatomy and functions of the prostate gland, to get a clear understanding of the male Genito-Urinary System.
PROSTATE PATHOLOGY Emad Raddaoui, MD, FCAP, FASC 1.
Prostate Cancer Screening Assistant Professor Charles Chabert Men’s health Seminar Ballina April 2011 prostates.com.au.
Lecture Fourteen Biomedical Engineering for Global Health.
Akbar Ashrafi Surgical Students Society of Melbourne September 2010.
Professor Abhay Rane OBE
The Detection of Bone Metastases in Patients with High-Risk Prostate Cancer: 99 mTc-MDP Planar Bone Scintigraphy, Single- and Multi-Field-of-View SPECT,
LUNG CANCER Dr.Mohammadzadeh. Lung cancer is the leading cancer killer in the United States. Every year, it accounts for 30% of all cancer deaths— more.
Should I have that blood test for Prostate Cancer?
Prostate Cancer Case Presentation Shireen Siddiqui.
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
Neoplasms of the Prostate Gland
Role of Biomarkers in Management of Prostate Cancer Dr. Angela Amayo Specialist Pathologist 13 th April 2012.
Principles of Surgical Oncology Salah R. Elfaqih.
Principles of Surgical Oncology Salah R. Elfaqih.
Asim Pasha.  Common condition seen in older men  Risk factors  1-age:  Around 50% of 50-year-old men will have evidence of BPH and 30% will have symptoms.
Prostate cancer Tim Bracey Histopathology. Prostate cancer What are we going to talk about? Anatomy of prostate Anatomy of prostate Very basic histology!
A 74 year old man underwent open prostatectomy due to moderate to severe urinary symptoms unresponsive to medical therapy. Preoperative PSA was 4.1 Postoperatively.
Carcinoma of prostate 1. Incidence ❏ most prevalent cancer in males ❏ second leading cause of male cancer deaths ❏ lifetime risk of a 50 years man for.
All about PSA (not Pharmaceutical Society of Australia)
Prostate Pathology Emad Raddaoui, MD, FCAP, FASC.
CASE 1 65-year-old man No other diseases or previous surgeries July 2005: PSA 11.5 ng/ml; F/T: 9% After prostate biopsy revealing adenocarcinoma: RETROPUBIC.
Male Reproductive System Kristine Krafts, M.D.. Male Reproductive System Outline Testis Prostate.
Prostate Cancer Screening Risk Management Ben Inch.
PROSTATE CANCER SCREENING Dan O’Connell, MD Dept of Family Medicine 2/4/05.
Prostate Pathology. Prostate weighs 20 grams in normal adult Retroperitoneal organ,encircling the neck of bladder and urethra Devoid of a distinct capsule.
Prostate Screening in the New Millennium Dr Pamela Ajayi MD PathCare.
Prostate Dr. Amitabha Basu MD.
بسم الله الرحمن الرحيم. The role of three dimensional transrectal ultrasonography (3-D TRUS) and power Doppler sonography in prostatic lesions evaluation.
Prostate Pathology Shaesta Naseem
Understanding Cancer and Related Topics
Blood and Tissue Based Molecular Signatures in Predicting Prostate Cancer Progression Tarek A. Bismar, MD Professor, University of Calgary Departments.
Prostate Dr. Atif Ali Bashir MD. Prostate Pathology ► Prostate weighs 20 grams in normal adult ► Retroperitoneal organ,encircling the neck of bladder.
Carcinoma of the Prostate Prof. Saad Dakhil. Prostate Cancer Definition Relevance –Most common noncutaneous malignancy in men Incidence –Nearly 200,000.
Prostate cancer update Suresh GANTA Consultant urological surgeon Manor Hospital.
Reference: Robbins & Cotran Pathology and Rubin’s Pathology
Carcinoma of the prostate. INTRODUCTION Prostate cancer is the most common cancer diagnosed and is the second leading cause of cancer death in men in.
Canadian Undergraduate Urology Curriculum (CanUUC): Prostate Diseases
Prostate Pathology Sufia Husain. Pathology Department KSU, Riyadh
Carcinoma of Prostate Issam S. Al-Azzawi, MD,FICMS,FEBU By
Prostate Pathology Sufia Husain. Pathology Department KSU, Riyadh
Carcinoma of the prostate
Male Reproductive System
Reference: Robbins & Cotran Pathology and Rubin’s Pathology
Emad Raddaoui, MD, FCAP, FASC
Bladder Cancer and Prostatic Cancer
Prostate cancer นพ.ชัชชัย หอมเกตุ.
Prostate Cancer Dr .Gehan Mohamed.
BME 301 Lecture Fourteen.
CONVERSATIONS ON PROSTATE CANCER
Advances in the Treatment of Metastatic Prostate Cancer
RADICAL PROSTATECTOMY BY; Dr HASSANZADEH
Presentation transcript:

Prostate Cancer Prostate cancer is the most common cancer detected in American men. The lifetime risk of a 50-year-old man for latent CaP is 40%; for clinically apparent CaP, 9.5%; and for death from CaP, 2.9%.

Risk Factor AgingRace A positive family history of CaP Diet: low fat, plant-based diet, Total fat intake, animal fat intake, and red meat intake Previous vasectomy

Pathology Adenocarcinoma(95%) Others: TCC Neurendocrine tumor Neurendocrine tumor Sarcoma Sarcoma Approximately, 60–70% of cases of CaP originate in the peripheral zone, while 10– 20% originate in the transition zone, and 5–10% in the central zone. Approximately, 60–70% of cases of CaP originate in the peripheral zone, while 10– 20% originate in the transition zone, and 5–10% in the central zone.

Pathology The Gleason grading system is the most commonly employed grading system. Gleason grading system that relies upon the low-power appearance of the glandular architecture under the microscope. Gleason grading system that relies upon the low-power appearance of the glandular architecture under the microscope. In assigning a grade to a given tumor, pathologists assign a primary grade to the pattern of cancer that is most commonly observed and a secondary grade to the second most commonly observed pattern in the specimen. In assigning a grade to a given tumor, pathologists assign a primary grade to the pattern of cancer that is most commonly observed and a secondary grade to the second most commonly observed pattern in the specimen.

Gleason grade 1&2

Gleason grade 3-4&5

Pathology Well-differentiated tumors havea Gleason sum of 2–4, Well-differentiated tumors havea Gleason sum of 2–4, Moderately differentiated tumors have a Gleason sum of 5–6, Poorly differentiatedtumors have a Gleason sum of 8–10. Poorly differentiatedtumors have a Gleason sum of 8–10.

Premalignant lesions

Symptoms Most patients with early-stage CaP are asymptomatic. The presence of symptoms often suggests locally advanced or metastatic disease. Obstructive or irritative voiding complaints Bone pain Spinal cord compression Spinal cord compression

Serum tumor marker PSA is a serine protease produced by benign and malignant prostate tissues. It circulates in the serum as uncomplexed (free or unbound) or complexed (bound) forms. Normal PSA values are those ≤4 ng/mL.

The positive predictive value of a serum PSA between 4nd 10 ng/mL is approximately 20–30%. The positive predictive value of a serum PSA between 4nd 10 ng/mL is approximately 20–30%.

PSA Variants PSA density—PSA levels are elevated approximately0.12 ng/mL/g of BPH tissue. PSA density—PSA levels are elevated approximately0.12 ng/mL/g of BPH tissue. Some investigators advocate prostate biopsy only if the PSA density exceeds 0.1 or 0.15.

PSA velocity—PSA velocity refers to the rate of change of serum PSA. Patients whose serum PSA increases by 0.75 ng/mL/y appear to be at an increased risk of harboring cancer.

Age adjusted PSA

Diagnosis Serum tumor marker DRE TRUS biopsy of prostate CT Scan Bone Scan

Treatment Radical Prostatectomy RadiotherapySurveillance Watchful waiting Hormone therapy Other treatment

The most prostatic carcinomas are hormone dependent anthat approximately 70–80% of men with metastatic Carespond to various forms of androgen deprivation. Testosterone, is produced by the Leydig cells in the testes (95%), Free testosterone enters prostate cells and is converted to dihydrotestosterone (DHT), the major intracellular androgen DHT binds to a cytoplasmic receptor protein and the complex moves to the cell nucleus, where it modulate transcription. Free testosterone enters prostate cells and is converted to dihydrotestosterone (DHT), the major intracellular androgen DHT binds to a cytoplasmic receptor protein and the complex moves to the cell nucleus, where it modulate transcription.